Exam 4 lecture 1 Flashcards

1
Q

What are the definitions of intraperitoneal and retroperitoneal organs? What are the organs?

A

Intraperitoneal- Completely covered with Visceral peritoneum
- Stomach
- 1st part Duodenum
-Jejunum
-Ileum
-Transverse colon
-Sigmoid colon
-Liver
-spleen

Retroperitoneal- partially covered with peritoneum
-Kidneys
-Ureters
-Suprarenal glands
-Rectum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name the types of intra abdominal infections

A
  1. Diverticulitis (+/- perforation/abscess)
  2. Appendicitis (+/- rupture)
  3. Cholecystitis
  4. Intra abdominal abscess
  5. Peritoneal dialysis related peritonitis
  6. Spontaneous bacterial peritonitis
  7. Necrotizing pancreatitis
  8. Cholangitis
  9. Cholecystitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is primary peritionitis? Diseases?

A
  1. peritoneal dialysis related peritonitis
  2. Spontaneous bacterial peritonitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the secondary peritonitis

A

diverticulitis
appendicitis
Cholecystitis
Cholangitis
Necrotizing pancreatitis
Intra abdominal abscess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define uncomplicated and complicated infection

A

Uncomplicated infection
- Confined within visceral structure (gall bladder, liver, spleen, kidneys)
- does not extend into peritoneum

Complicated infection
-extends beyond a single organ into peritoneal space and associated with peritonitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

WHo is at highest risk for SBP (spontaneous bacterial contamination)? Most common monomicrobial? Source of contamination?

A

No obvious source for contamination

patient at highest risk- Hepatic failure and ascites- alcoholic cirrhosis

E coli is most common monomicrobial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Clinical presentation of SBP

A

-Abdominal pain
-N/V/D
-Fevers, chills\reduced/absent bowel sounds
-altered mental status/encephalopathy (especially in pts with alcoholic cirrhosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is needed for diagnosis of SBP

A

S/s of infection
Ascitic fluid analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What lab results do we look at for ascitic fluid analysis of SBP (What number suggests)

A

TNC x Bands/neutrophils bdy fluid= ANC
absolute neutrophil count > 250 is SBP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the recommended empiric treatment options of SBP

A

Ceftriaxone**
Cefepime
Piperacillin/tazobactam
Meropenem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What to consider in tx of SBP if risk for MRSA present

A

Consider addition of Vancomycin, linezolid, daptomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What to use for anaerobic coverage for SBP

A

B lactam/ B lactamase inhibitor

Carbapenem

Metronidazole (ceftriaxone, cefepime)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SBP tx duration

A

5-7 days

14-21 days for peritonitis patients undergoing CAPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What to use for secondary prophylaxis for SBP

A

TMP/SMX, PO QD or ciprofoxacin 500 mg PO QD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

most common microorganisms for secondary intra abdominal infections

A

POLYMICROBIAL
aerobic (-)- E coli
Aerobic (+)- strep viridians
Anaerobic bacteria- bacteroides
Fungi- candida

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What makes secondary intra abdominal infections so unique

A

Multiple organ systems affected
- GI tract- bowel paralysis
- CV- fluid shifts
- Respiratory- hypoxemia
- Renal- decreased renal perfusion

bacterial synergy
- enterobacterales creates perfect envt for anaerobes
-anaerobes cause abscess and have several virulent factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

s/s of secondary intrabadominal infections

A

-abdominal pain and distention
- N/V
-Fevers +/- chills
- loss of appetite
- Inability to pass flatus and/or feces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

physical exam/ vital signs of secondary intra abdominal infections

A

Tachypnea, tachycardia
Hypotension
SIgnificant abdominal tenderness
Rigidity of abdominal wall
Reduced or absent bowel sound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the two pillars of intra abdominal infection tx

A

Source control
Antimicrobial therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are examples of source control procedures? Why are they important?

A
  • Repair perforations
  • resection of ifected organs/tissue
  • Removal of foreign material
  • Drain purulent collections

Important to obtain cultures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the 3 main considerations for empiric antibiotic selection for secondary intra abdominal infection

A
  1. select agent or combination of agents with high likelihood to cover common organisms. (must look at local antibiogram)
  2. Consider if enterococci coverage is necessary
  3. consider if antifungal coverage is required
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

When are agents not recommended for intra abdominal infections?

A

agents not recommended if resistance rates exceed 10-20% for e coli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When is enterococci coverage not necessary for IAI?

A

(not necessary for mild- moderate severity of community acquired IAI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

When is enterococci coverage necessary for IAI

A

high severity IAI
hx of recent cephalosporin use
immunocompromised
biliary source of infection
hx of valvular heart disease
prosthetic intravascular material

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

when can we consider antifungal coverage

A

only add if isolated in culture

May consider if patient not improving on appropriate antibiotic therapy

26
Q

empiric antibiotic regimen for community acquired mild-moderate secondary IAI

A

enterococci not covered
- ceftriaxone
-cefazolin
- ciprofloxacin
- levofloxacin
cefoxitin
- Ertapenem
- Tigecycline

27
Q

Empiric therapy for community qcquired high severity and healthare associated IAI

A

Piperacillin/tazobactam
Meropenem
Cefepime
Ciprofloxacin
Levofloxacin

28
Q

secondary IAI candida albicans (fungi) tx? Non albican tx

A

Flucanozole

use micafungin if treating candida species other than albicans on culture

29
Q

Is ampicillin/sulbactam included in tx of IAI

A

no, e coli resistance is high for ampicillin/sulbactam

30
Q

What is a note about IAI about anaerobic bacteria

A

Common to maintain anaerobic coverage even if culture does not isolate anaerobic bacteria

31
Q

common oral antibiotic regimens for IAI for de escalation

A

Amox/clav (can be dosed TID)
Cefpodoxime

if possible confirm susceptbility
Cephalexin
Cefadroxil
Ciprofloxacin
Levofloxacin
TMP/SMX

32
Q

Tx duration for general tx, diverticulitis, appendicitis, cholecystitis, bowel injuries repaired within 12 hrs

A

general tx duration- 4-7 days after source control
Diverticulitis- uncomplicated- no antibiotic, moderate/severe- 5-10 days
appendicitis, cholecystitis and bowel injuries- 24 hrs

33
Q

which organisms do not need to be covered empirically for appendicitis, e coli, enterococcus, bacteroides, s. aureus

34
Q

do ceftriaxone or metronidazole cover enterococcus?

35
Q

What type of microbe is c diff

A

Gram positive
spore forming
Obligate anaerobic

36
Q

two toxins procuded by c diff? What is the more virulent strain?

A

TcdA (inflammatory enterotoxinc) and TcdB (cytotoxin)

BI/NAP1/027 (high severity and toxicity)

37
Q

How is C diff transmitted from person to person

A

Fecal-oral route through spores

38
Q

C diff risk factors

A

Antibiotic exposure
Healthcare exposure
age > 65
proximity to person with C diff
Chemo
GI surgery
Immunosuppression
use of antacids

39
Q

what are the antibiotics with highest risk for C diff

A

fluoroquinolones
clindamycin
3rd/4th gen cephalosporins (specifically ceftriaxone)
carbapenems

40
Q

pathogenesis of c diff

A

disruption of colonic microflora

source and introduction of C diff to colon

Multiplication of c diff

colon becomes edematous

41
Q

two primary symptoms of c diff

A

profuse, watery or mucoid green, foul smelling diarrhea

abdominal pain

42
Q

When to test for C diff? 3 testing methods for C diff?

A

When to test- 3 or more profuse, watery or mucoid green, foul smelling stools in 24 hrs

3 tests
1. nucleic acid amplification test (NAAT) alone
2. antigen test (GDH) + toxin A/B test
3. NAAT + toxin A/B test

43
Q

is repeat testing for C diff recommended

44
Q

s/s of different C diff classifications

A

Non severe- WBC< 15,000
Scr < 1.5
severe- WBC > 15,000
Scr > 1.5
Fulminant- hypotension or shock, toxic megacolon

45
Q

What are the different C diff treatment options

A

Oral vancomycin (standard of care)
Fidaxomixin (narrower spectrum)
metronidazole- no longer 1st line

46
Q

PK/PD of oral vanc

A

extremely poor oral absorption
C diff only indication for oral vanc

47
Q

doses of oral vanc

A

standard- vanc 125 mg PO Q6h
fulminant- vanc 500 mg PO Q 6H

48
Q

biggest barrier to fidaxomicin

A

4500 dollar cost of use

49
Q

c diff infection treatment for initial episode non severe and initial episode severe

A

initial episode non severe- Fidaxomicin, vancomicin, metronidazole (only if other options unavailable/unfeasible)

Initial episode severe- fidaxomicin
vancomycin

50
Q

would u recommend loperamide for c diff

51
Q

general approach with recurrent c diff

A

change something, either drug or dosing regimen

52
Q

What treatment options to use for first CDI recurrence (in order of preference)? Second or subsequent CDI recurrence

A

-Fidoxomicin 200 mg PO BID x 10 days
-Vancomycin 125 mg PO Q6H x 10 days
- Fidaxomicin 200 mg PO BID x 5 days, then 200 mg PO every other day x 20 days
- Vanc tapered and pulsed

Second recurrence- same drugs, just select different treatment

53
Q

How to treat fulminant CDI? WHat if ileus present?

A

Vancomycin 500 mg PO Q6H

+ Metronidazole 500 mg IV Q 8H

IF ILEUS PRESENT, consider adding vanc 500 mg rectally q6h

54
Q

What are the 3 biggest risk factors for CDI recurrence

A

Age> or = 65
Immunocompromised host
Severe CDI on presentation

55
Q

What is FMT? Potential indications?

A
  • administration of fecal material from a healthy person to restore a balanced gut microbiome
  • Utilized as both a treatment option and method to reduce reccurence

Indication
- 3 or more episodes of CDI
- Poor response to initial antibiotic therapy for CDI

56
Q

What is rebyota? Compare to other FMTs

A

Fecal microbiota suspension

administered via rectal tube 24-72 hrs after tx completion

57
Q

compare vowst to rebyota

A

Vowst us bacterual spore suspension (oral)

4 capsules PO x 3 days starting 2-4 days after tx completion

58
Q

Compare bezlotoxumab to other drugs used after FMT

A

Benzlotoxumab is a monoclonal antibody targeting C diff toxin B to neutralize itseffect

IV x 1 dose during CDI tx

59
Q

what to be careful of when giving bezlotoxumab

A

Caution in pts with CHF (increased risk for mortality and CHF)

60
Q

who should not receive probiotics

A

Bowel perforation patients
patients in ICU

61
Q

Do patient applications at 1 hour 24 mins on march 10 lecture